Research Topics
| T A KetterSummaryAffiliation: Stanford University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Adjunctive aripiprazole in treatment-resistant bipolar depressionTerence A Ketter
Stanford University School of Medicine, Stanford, CA, USA
Ann Clin Psychiatry 18:169-72. 2006..There are limited management options for treatment-resistant depression in bipolar disorder (BD) patients...
Long-term effectiveness of quetiapine in bipolar disorder in a clinical settingTerence A Ketter
Stanford University School of Medicine, Stanford, CA 94305 5723, USA
J Psychiatr Res 44:921-9. 2010..To assess quetiapine effectiveness in bipolar disorder (BD) patients in a clinical setting...
The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disordersTerence A Ketter
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Calif 94305, USA
J Clin Psychiatry 64:15-20. 2003..We review the efficacy and tolerability of these diverse treatment options in bipolar disorders and explore possible relationships between clinical effects and GABAergic and antiglutamatergic mechanisms of action...
Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute maniaTerence A Ketter
Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford, California 94305 5723, USA
J Affect Disord 100:S45-53. 2007..To evaluate the effects of quetiapine monotherapy compared with placebo on acute (3-week) and more sustained (12-week) rates of response and remission/euthymia in bipolar disorder patients with acute mania...
Potential mechanisms of action of lamotrigine in the treatment of bipolar disordersTerence A Ketter
Bipolar Disorders Clinic, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA
J Clin Psychopharmacol 23:484-95. 2003..Although lamotrigine mechanisms overlap those of other mood-stabilizing anticonvulsants, important dissociations suggest candidate mechanisms, which could contribute to lamotrigine's distinctive psychotropic profile...
Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia?Terence A Ketter
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Bipolar Disorders Clinic, Room 2124, 401 Quarry Road, Stanford, CA 94305 5723, USA
J Psychiatr Res 38:47-61. 2004....
The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trialTerence A Ketter
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, Calif, USA
J Clin Psychiatry 67:400-6. 2006..This study assessed the impact of specific instructions designed to decrease risk of dermatologic reactions, including nonserious rash, during initiation of and early treatment with lamotrigine in patients with bipolar I disorder...
Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practiceTerence A Ketter
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 5723, USA
Curr Med Res Opin 22:2345-53. 2006..To assess the perceptions of clinicians in the psychiatric community about pharmacotherapy and its impact on weight gain and adverse metabolic effects in patients with bipolar disorder...
Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?T A Ketter
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA
Acta Psychiatr Scand 123:175-89. 2011..To compare bipolar treatment interventions, using number needed to treat (NNT) and number needed to harm (NNH)...
Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remissionTerence A Ketter
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305 5723, USA
J Psychiatr Res 44:8-14. 2010..To assess rapid antipsychotic efficacy with oral ziprasidone monotherapy in bipolar acute manic/mixed episodes with psychotic features, and predictive value of rapid antipsychotic response for subsequent acute manic/mixed episode remission...
Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorderTerence A Ketter
Stanford University School of Medicine, Stanford, CA 94305, USA
Psychopharmacol Bull 39:120-46. 2006..Further investigation of combinations of agents such as mood stabilizers and atypical antipsychotics may yield valuable insights into the potential of combination therapies to enhance clinical outcomes in patients with bipolar disorder...
Effectiveness of lamotrigine in bipolar disorder in a clinical settingTerence A Ketter
Stanford University School of Medicine, 401 Quarry Road, Room 2124, Stanford, CA, USA
J Psychiatr Res 43:13-23. 2008..To assess lamotrigine effectiveness in bipolar disorder (BD) patients in a clinical setting...
Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rashTerence A Ketter
Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305, USA
J Clin Psychiatry 66:642-5. 2005..To assess treatment-emergent rash incidence when using dermatology precautions (limited antigen exposure) and slower titration during lamotrigine initiation...
Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorderTerence A Ketter
Department of Psychiatry and Behavior Sciences and Bipolar Disorders Clinic, Stanford University School of Medicine, 401 Quarry Rd, RM 2124, Stanford, CA 94305 5723, USA
J Clin Psychiatry 69:9-15. 2008..The decision to use a combination therapy should be made on the basis of the efficacy, tolerability, and safety of each medication and their specific combination for individual patients...
Divalproex extended-release in acute bipolar II depressionP W Wang
Stanford University School of Medicine, Stanford, CA, USA
J Affect Disord 124:170-3. 2010..Divalproex extended-release (divalproex-ER) is effective in acute mania, and limited data suggest divalproex may have efficacy in acute bipolar depression...
Mood stabilizer augmentation with olanzapine in acutely manic childrenK D Chang
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, California 94305 5540, USA
J Child Adolesc Psychopharmacol 10:45-9. 2000..Adverse effects included sedation and weight gain. These results suggest that olanzapine may have an antimanic or mood stabilizing effect in acutely manic children with bipolar disorder...
Psychiatric phenomenology of child and adolescent bipolar offspringK D Chang
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305 5540, USA
J Am Acad Child Adolesc Psychiatry 39:453-60. 2000..To establish prodromal signs of and risk factors for childhood bipolar disorder (BD) by characterizing youths at high risk for BD...
Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodesTerence A Ketter
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA
J Clin Psychiatry 67:95-101. 2006..Thus, olanzapine maintenance therapy may be particularly effective early in the course of bipolar illness...
Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trialRichard H Weisler
Department of Psychiatry and Behavioral Sciences, Duke University, 700 Spring Forest, Suite 125, Raleigh, NC 27609, USA
J Clin Psychiatry 66:323-30. 2005..In the present study, we further evaluated the efficacy and safety of monotherapy with beaded, extended-release carbamazepine capsules (ERC-CBZ) in patients with bipolar I disorder experiencing manic or mixed episodes...
A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodesTerence A Ketter
Stanford University School of Medicine, Stanford, California 94305-5723, USA
J Clin Psychiatry 65:668-73. 2004..Adverse events were generally mild to moderate and were typical of those associated with carbamazepine. Controlled studies are warranted to further explore the efficacy of beaded ERC-CBZ in preventing relapse in bipolar disorder...
Special issues in the treatment of paediatric bipolar disorderK D Chang
The Department of Psychiatry and Behavioural Sciences, Stanford University School of Medicine, USA
Expert Opin Pharmacother 2:613-22. 2001..Other novel agents are currently being investigated in adult BD and may prove applicable to the paediatric form. Finally, based on the available data, a treatment algorithm for PBD is proposed...
Toward interaction of affective and cognitive contributors to creativity in bipolar disorders: a controlled studyShefali Srivastava
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 5723, USA
J Affect Disord 125:27-34. 2010..Enhanced creativity in bipolar disorder patients may be related to affective and cognitive phenomena...
Combination therapy versus monotherapy in bipolar disorderTerence A Ketter
Department of Psychiatry and Behavior Sciences and Bipolar Disorders Clinic, Stanford University School of Medicine, Stanford, Calif, USA
J Clin Psychiatry 69:e34. 2008..Psychosocial therapy as an adjunct to medication is also useful in delaying relapse...
Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case reportO V Becker
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305-5723, USA
Bipolar Disord 6:435-9. 2004..Both of these issues merit systematic assessment...
Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depressionM E Winsberg
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Room 2124, Stanford, CA 94305-5723, USA
J Affect Disord 67:207-12. 2001....
A new US-UK diagnostic project: mood elevation and depression in first-year undergraduates at Oxford and Stanford universitiesR A Chandler
Stanford University School of Medicine, Stanford, CA, USA
Acta Psychiatr Scand 118:81-5. 2008..To investigate differences in prevalence of mood elevation, distress and depression among first-year undergraduates at Oxford and Stanford universities...
Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: a pilot studyPo W Wang
Stanford University School of Medicine, 401 Quarry Road, Suite 2117, Stanford, CA 94305 5723, United States
J Psychiatr Res 42:451-7. 2008..To assess the effectiveness and tolerability of open adjunctive zonisamide in treatment of obesity in euthymic bipolar disorder (BD) patients...
Preliminary evidence of differential relations between prefrontal cortex metabolism and sustained attention in depressed adults with bipolar disorder and healthy controlsJohn O Brooks
Palo Alto Veterans Affairs Health Care System, Palo Alto, CA 94304, USA
Bipolar Disord 8:248-54. 2006..To assess the relations between sustained attention as assessed by the Continuous Performance Test (CPT) and subgenual and dorsolateral prefrontal cortex metabolism in depressed patients with bipolar disorders and healthy controls...
Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: preliminary reportWendy K Marsh
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, United States
J Psychiatr Res 42:247-51. 2008..The menopausal transition in women without mood disorders is associated with an increase in depression. This study assesses mood course during the menopausal transition in women with bipolar disorder...
The link between bipolar disorders and creativity: evidence from personality and temperament studiesShefali Srivastava
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305, USA
Curr Psychiatry Rep 12:522-30. 2010....
Clinical use of carbamazepine for bipolar disordersPo W Wang
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, CA, USA
Expert Opin Pharmacother 6:2887-902. 2005..This paper reviews the chemistry, pharmacodynamics and pharmacokinetics of CBZ, as well as reviews of the controlled trials of CBZ in acute bipolar mania, acute bipolar depression and bipolar maintenance treatment...
Overweight and obesity in bipolar disordersPo W Wang
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Room 2117, CA 94305-5723, USA
J Psychiatr Res 40:762-4. 2006
Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentinBarbara R Sommer
Stanford University School of Medicine, Department of Psychiatry, Stanford, CA 94305 5723, USA
Expert Opin Drug Saf 6:133-45. 2007..5-10.5 h, may cause ataxia. Oxcarbazapine, hepatically reduced, may cause hyponatremia, and topiramate may cause significant cognitive impairment. Nonetheless, these are important medications to consider in the treatment of agitation...
Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depressionJohn T Little
Division of Psychiatric Neuroimaging, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Biol Psychiatry 57:220-8. 2005....
Atypical antipsychotics for acute manic and mixed episodes in children and adolescents with bipolar disorder: efficacy and tolerabilityManpreet K Singh
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305, USA
Drugs 70:433-42. 2010..Additional longitudinal and biological studies are warranted to characterize the effects of atypical antipsychotics on all phases and stages of bipolar illness development in children and adolescents...
New anticonvulsant medication uses in bipolar disorderPo W Wang
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California, USA
CNS Spectr 8:930-2, 941-7. 2003....
Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studiesTerence A Ketter
Department of Psychiatry and Behavioral Sciences, Bipolar Disorders Clinic, Stanford University School of Medicine, CA 94305 5273, USA
J Clin Psychiatry 63:21-5. 2002..Although it is not yet a clinical tool for bipolar disorders, brain imaging provides useful research data to understand the fundamental neurobiology of mood disorders and to more effectively target therapeutics...
Temperament characteristics of child and adolescent bipolar offspringKiki D Chang
Department of Psychiatry and Behavioral Sciences, Division of Child Psychiatry and Child Development, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305 5719, USA
J Affect Disord 77:11-9. 2003..We wished to characterize temperament of children at high risk for bipolar disorder (BD)...
Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclatureTerence A Ketter
Department of Psychiatry and Behavioral Science, Stanford University School of Medicine, Calif 94305 5723, USA
J Clin Psychiatry 63:146-51. 2002..In this article, the treatment options for bipolar disorder, with a focus on depression and rapid cycling, are discussed according to this new conceptualization of management from below and above baseline...
Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitusNatalie L Rasgon
Stanford Center for Neuroscience in Women s Health, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5723, USA
Bipolar Disord 12:504-13. 2010..Family history of type 2 diabetes mellitus (FamHxDM2), which has been shown to have deleterious effects on metabolic function in the general population, may play a role in the metabolic dysfunction observed in BD...
Impaired recognition of facial emotion in maniaAnna Lembke
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305 5723, USA
Am J Psychiatry 159:302-4. 2002..Recognition of facial emotion was examined in manic subjects to explore whether aberrant interpersonal interactions are related to impaired perception of social cues...
Gabapentin augmentation therapy in bipolar depressionPo W Wang
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5723, USA
Bipolar Disord 4:296-301. 2002..Gabapentin (GBP) may be useful in bipolar disorders, including as adjunctive therapy for bipolar depression, although controlled studies suggest inefficacy as primary treatment for mania or treatment-resistant rapid cycling...
Bipolar disorder: improving diagnosis and optimizing integrated careJ L Culver
Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford, CA 94305, USA
J Clin Psychol 63:73-92. 2007..This review seeks to update psychologists and related healthcare professionals on recent advances and the current limitations in the diagnosis and treatment of bipolar disorder...
Family environment of children and adolescents with bipolar parentsK D Chang
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305 5540, USA
Bipolar Disord 3:73-8. 2001..We sought to characterize families with children at high risk for developing BD in order to better understand the contributions of family environment to the development of childhood BD...
Pharmacokinetics of mood stabilizers and new anticonvulsantsPo W Wang
Department of Psychiatry and Behavioral Sciences, Bipolar Disorders Clinic, Stanford University School of Medicine, 401 Quarry Road, Room 2117, Stanford, CA 94305-5723, USA
Psychopharmacol Bull 36:44-66. 2002..Novel psychotropic effects of these drugs may also be demonstrated, based on their mechanisms of action and preliminary clinical data...
Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disordersSuttiporn Janenawasin
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305-5723, USA
Bipolar Disord 4:328-34. 2002..Controlled studies are warranted to further explore these preliminary observations...
Treating bipolar disorder: monotherapy versus combination therapyTerence A Ketter
Department of Psychiatry and Behavior Sciences and the Bipolar Disorders Clinic, Stanford University School of Medicine, Stanford, CA, USA
J Clin Psychiatry 70:e42. 2009..Physicians should exercise caution when treating patients with a combination of medications and strive to use monotherapy when feasible...
Dorsolateral and dorsomedial prefrontal gray matter density changes associated with bipolar depressionJohn O Brooks
Palo Alto Veterans Affairs Health Care System, Psychiatry Service, Palo Alto, CA, USA
Psychiatry Res 172:200-4. 2009..Moreover, our observed differences in gray matter density overlap metabolic areas of change and thus have implications for the conceptualization and treatment of affective disorders...
Biology and recent brain imaging studies in affective psychosesP W Wang
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305 5723, USA
Curr Psychiatry Rep 2:298-304. 2000..We review brain imaging studies that have advanced our knowledge of psychosis in mood disorders, with respect to the continuum versus discrete entity hypotheses...
Temperament-creativity relationships in mood disorder patients, healthy controls and highly creative individualsConnie M Strong
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Room 2124, Stanford, CA 94305 5723, USA
J Affect Disord 100:41-8. 2007..To investigate temperament-creativity relationships in euthymic bipolar (BP) and unipolar major depressive (MDD) patients, creative discipline controls (CC), and healthy controls (HC)...
Creativity in familial bipolar disorderDiana I Simeonova
Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, Stanford University School of Medicine, Stanford, CA 94305 5540, USA
J Psychiatr Res 39:623-31. 2005....
The diverse roles of anticonvulsants in bipolar disordersTerence A Ketter
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305-5723, USA
Ann Clin Psychiatry 15:95-108. 2003..The categorical-mechanistic extension strives to address this issue, but requires systematic clinical investigation of more precise relationships between psychotropic profiles and discrete mechanisms of action to assess its merits...
Enhanced creativity in bipolar disorder patients: a controlled studyClaudia M Santosa
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305 5723, USA
J Affect Disord 100:31-9. 2007..We assessed non-eminent creativity in euthymic bipolar (BP) and unipolar major depressive disorder (MDD) patients, creative discipline controls (CC), and healthy controls (HC)...
Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controlsCecylia Nowakowska
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Room 2350, Stanford, CA 94305-5723, USA
J Affect Disord 85:207-15. 2005....
Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement ProgramAnna Lembke
Stanford University School of Medicine, CA, USA
J Psychiatr Pract 10:81-7. 2004..Potential moderators, such as insurance status and availability of care, should be examined in future studies...
Incorporating trial data into bipolar disorder managementTerence A Ketter
Department of Psychiatry, Stanford University School of Medicine, Stanford, California, USA
J Clin Psychiatry 69:e21. 2008..These interventions, combined with judicious pharmacotherapy, can help minimize the impact of adverse effects and related nonadherence so that patients can achieve affective stability, regain psychosocial function, and maintain health...
Lamotrigine plus quetiapine combination therapy in treatment-resistant bipolar depressionYong M Ahn
Department of Neuropsychiatry, Seoul National University Hospital, Department of Psychiatry and Behavioral Science, Seoul National University College of Medicine, Chongno Gu, Seoul, Republic of Korea
Ann Clin Psychiatry 23:17-24. 2011..Lamotrigine and quetiapine are commonly used in bipolar disorder, but there are no published systematic studies of their use in combination for treatment-resistant bipolar depression...
Omega-3 fatty acids in bipolar disorder: clinical and research considerationsLauren B Marangell
Mood Disorders Center, Menninger Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA
Prostaglandins Leukot Essent Fatty Acids 75:315-21. 2006..Our pilot trial of DHA in women who plan to stop conventional psychotropics in order to conceive suggests that such trials are feasible...
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depressionJoseph R Calabrese
University Hospitals of Cleveland and Case University School of Medicine, 11400 Euclid Ave, Suite 200, Cleveland, OH 44106, USA
Am J Psychiatry 162:1351-60. 2005..There is a major unmet need for effective options in the treatment of bipolar depression...
Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depressionPaul E Keck
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
J Clin Psychiatry 66:611-6. 2005..These subanalyses compare treatment-emergent mania rates in bipolar I depressed patients treated with olanzapine, placebo, or olanzapine/fluoxetine combination...
Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depressionRobert T Dunn
Biological Psychiatry Branch, NIMH, NIH, Bethesda, Maryland 20892-1272, USA
Biol Psychiatry 51:387-99. 2002..Thus, different depressive symptom clusters may have different neural substrates in unipolars, but clusters and their substrates are convergent in bipolars...
Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric maniaRobert W Baker
Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA
Br J Psychiatry 185:472-8. 2004..Few controlled studies examine the treatment of depressive features in mania...
Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement ProgramChristopher D Schneck
Department of Psychiatry, University of Colorado Health Sciences Center, 4455 East 12th Ave, Box A011 15, Denver, CO 80220, USA
Am J Psychiatry 161:1902-8. 2004..This study compared demographic and phenomenological variables between bipolar patients with and without rapid cycling as a function of bipolar I versus bipolar II status...
A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodesRichard H Weisler
Department of Psychiatry and Behavioral Science, Duke University, 700 Spring Forest, Suite 125, Raleigh, N C 27609, USA
J Clin Psychiatry 65:478-84. 2004..We assessed the efficacy and safety of monotherapy with beaded, extended-release carbamazepine capsules (ERC-CBZ; SPD417) in bipolar disorder patients with manic or mixed episodes...
Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BDLauren B Marangell
Mood Disorders Program, Department of Psychiatry, Baylor College of Medicine, Houston, TX 77030, USA
Bipolar Disord 6:139-43. 2004..To describe the frequency and correlates of lamotrigine therapy among the first 500 patients enrolled into the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study...
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depressionMauricio Tohen
Lilly Research Laboratories, Indianapolis, IN 46285, USA
Arch Gen Psychiatry 60:1079-88. 2003....
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week studyMauricio Tohen
Lilly Research Laboratories, IN 46285, USA
Am J Psychiatry 160:1263-71. 2003..Few double-blind trials have compared longer-term efficacy and safety of medications for bipolar disorder. The authors report a 47-week comparison of olanzapine and divalproex...
Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?Xiaohua Li
Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294 4400, USA
J Affect Disord 69:1-14. 2002..Understanding the mechanisms of anticonvulsant mood stabilizers, integrated with clinical observations, may ultimately provide important new insights into the pathophysiology and treatment of bipolar disorders...
Age, sex and laterality effects on cerebral glucose metabolism in healthy adultsMark W Willis
Biological Psychiatry Branch, National Institute of Mental Health, 10 Center Drive MSC 1272, Bethesda, MD 20892 1272, USA
Psychiatry Res 114:23-37. 2002..These findings contribute toward a convergence in the literature, and the regression models of CMRglc vs. age serve as a normative database to which patients may be compared...
Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disordersGabriela V Obrocea
National Institute of Mental Health, Biological Psychiatry Branch, Bethesda, Maryland 20892, USA
Biol Psychiatry 51:253-60. 2002..These preliminary data in a treatment refractory subgroup may help in the further definition of the range of clinical utility of these widely used anticonvulsants...
Regional cerebral glucose utilization in patients with a range of severities of unipolar depressionTim A Kimbrell
North Little Rock VA Medical Center (TAKi, North Little Rock, Arkansas, USA
Biol Psychiatry 51:237-52. 2002..CONCLUSIONS: Areas of frontal, cingulate, insula, and temporal cortex appear hypometabolic in association with different components of the severity and course of illness in treatment-resistant unipolar depression...
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorderTrisha Suppes
Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX 75390 9121, USA
J Clin Psychiatry 66:870-86. 2005..The guidelines for evaluating possible medications, the criteria for selection and ranking, and the updated algorithms are described...
Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new dataHagop S Akiskal
University of California, San Diego, USA
CNS Spectr 10:suppl 1-11; discuss 12-3; quiz 14-5. 2005..Further efforts are needed to update physicians on the use of carbamazepine relative to other medications in the treatment of bipolar disorder...
Preliminary findings of uncoupling of flow and metabolism in unipolar compared with bipolar affective illness and normal controlsRobert T Dunn
Biological Psychiatry Branch, National Institute of Mental Health, NIH, 10 Center Drive MSC 1272, Bethesda, MD 20892 1272, USA
Psychiatry Res 140:181-98. 2005....
The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trialsRichard H Weisler
University of North Carolina at Chapel Hill, NC, USA
CNS Spectr 11:788-99. 2006..This article provides an overview of data on the use of AEDs in bipolar disorder, including acute mania and depression, prophylaxis, and rapid cycling...
Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorderCharles L Bowden
Department of Psychiatry, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229 3900, USA
Am J Psychiatry 163:1199-201. 2006..This study assessed weight changes in a large cohort of patients with bipolar disorder who were treated with randomly assigned maintenance monotherapies...
Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literatureHenry A Nasrallah
Department of Psychiatry, University of Cincinnati, Cincinnati, OH 45267 0559, USA
J Affect Disord 95:69-78. 2006..Controlled and direct comparative studies, both short and long term, are needed to further clarify the differences between VPA and CBZ...
Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studiesJoseph R Calabrese
Department of Psychiatry, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, Ohio 44106, USA
Biol Psychiatry 59:1061-4. 2006..To assess the efficacy of lamotrigine or lithium in preventing mood recurrence (i.e., a new mood episode) in bipolar disorder...
Safety and tolerability of mood-stabilising anticonvulsants in the elderlyHoward H Fenn
Menlo Park Division, Palo Alto Veterans Affairs Healthcare System, Menlo Park, California 94025, USA
Expert Opin Drug Saf 5:401-16. 2006..Guidelines are offered for the safe use of these medications in the elderly, based on research literature...
Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trialsMark A Frye
Mood Disorders Research Program, University of California at Los Angeles, USA
J Clin Psychiatry 67:1721-8. 2006..Subsyndromal symptoms in bipolar disorder can cause significant functional impairment and are associated with relapse...
Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trialsRichard H Weisler
Department of Psychiatry and Behavioral Science, Duke University, Raleigh, North Carolina 27609, USA
CNS Drugs 20:219-31. 2006..By pooling data from these two trials, a more highly powered analysis of the efficacy and safety of CBZ-ERC in bipolar I disorder could be conducted...
Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)Roy H Perlis
Bipolar Clinical and Research Program, Massachusetts General Hospital, ACC 812, 15 Parkman Street, Boston, MA 02114, USA
Am J Psychiatry 163:217-24. 2006..The authors looked for the features associated with risk of recurrence...
Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidoneAndrew A Nierenberg
Massachusetts General Hospital Bipolar Clinic and Research Program, Suite 580, 50 Staniford Street, Boston, MA 02114, USA
Am J Psychiatry 163:210-6. 2006..This study represents the first randomized trial of competing options for treatment-resistant bipolar depression and assesses the effectiveness and safety of antidepressant augmentation with lamotrigine, inositol, and risperidone...
Focus on bipolar disorder treatmentCharles L Bowden
Department of Psychiatry, University of Texas Health Science Center at San Antonio, TX, USA
J Clin Psychiatry 66:1598-609. 2005
Introduction - advancing understanding of the effectiveness of quetiapine in acute maniaTerence A Ketter
J Affect Disord 100:S1-3. 2007
Effectiveness of adjunctive antidepressant treatment for bipolar depressionGary S Sachs
Bipolar Clinic and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
N Engl J Med 356:1711-22. 2007..Our study was designed to determine whether adjunctive antidepressant therapy reduces symptoms of bipolar depression without increasing the risk of mania...
Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorderJoseph F Goldberg
Affective Disorders Program, Silver Hill Hospital, New Canaan, Connecticut 06840, USA
Biol Psychiatry 63:125-30. 2008..The anticonvulsant lamotrigine has demonstrated efficacy for relapse prevention in bipolar disorder, but its possible mood-stabilizing properties on a day-to-day or week-to-week basis have not previously been investigated...
Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled studyJohn Cookson
The Department of Psychiatry, Royal London Hospital, London, UK
Int Clin Psychopharmacol 22:93-100. 2007..2%, quetiapine 300 mg/day: 3.9, and placebo: 3.9%). In conclusion, quetiapine compared with placebo significantly reduces time to response and remission compared with placebo, and has a favorable number needed to treat...
